- Home
- BOWN vs VERU Comparison
BOWN vs VERU Comparison
Compare BOWN & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOWN
- VERU
- Stock Information
- Founded
- BOWN 2023
- VERU 1971
- Country
- BOWN United States
- VERU United States
- Employees
- BOWN N/A
- VERU N/A
- Industry
- BOWN
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- BOWN
- VERU Health Care
- Exchange
- BOWN Nasdaq
- VERU Nasdaq
- Market Cap
- BOWN 100.3M
- VERU 107.2M
- IPO Year
- BOWN 2023
- VERU 1990
- Fundamental
- Price
- BOWN $10.92
- VERU $0.65
- Analyst Decision
- BOWN
- VERU Strong Buy
- Analyst Count
- BOWN 0
- VERU 4
- Target Price
- BOWN N/A
- VERU $4.00
- AVG Volume (30 Days)
- BOWN 40.2K
- VERU 1.1M
- Earning Date
- BOWN 01-01-0001
- VERU 02-06-2025
- Dividend Yield
- BOWN N/A
- VERU N/A
- EPS Growth
- BOWN N/A
- VERU N/A
- EPS
- BOWN 0.39
- VERU N/A
- Revenue
- BOWN N/A
- VERU $16,886,419.00
- Revenue This Year
- BOWN N/A
- VERU N/A
- Revenue Next Year
- BOWN N/A
- VERU N/A
- P/E Ratio
- BOWN $28.18
- VERU N/A
- Revenue Growth
- BOWN N/A
- VERU 3.62
- 52 Week Low
- BOWN $10.32
- VERU $0.36
- 52 Week High
- BOWN $10.98
- VERU $1.92
- Technical
- Relative Strength Index (RSI)
- BOWN 53.13
- VERU 42.01
- Support Level
- BOWN $10.93
- VERU $0.60
- Resistance Level
- BOWN $10.97
- VERU $0.82
- Average True Range (ATR)
- BOWN 0.02
- VERU 0.07
- MACD
- BOWN -0.01
- VERU -0.01
- Stochastic Oscillator
- BOWN 14.29
- VERU 22.32
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.